NSECertificate under SEBI (Depositories and Participants) Regulations, 20186 Oct 2026 · 6 Oct 2026, 03:24 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Alembic Pharmaceuticals Limited · APLLTD
✦ AI Summary
Alembic Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter and half year ended 30th September, 2026.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Alembic Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Attachments (1)
📄pdf
Download →
APLLTD_06102026152350_Certificate-74_5_-BSE-NSE-signed.pdf
View document text
Date: 6th October, 2026
To, To,
The Manager, The Manager,
BSE Limited National Stock Exchange of India Ltd.
P. J. Towers, Dalal Street, ‘Exchange Plaza’, Bandra Kurla Complex,
Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
BSE Scrip Code: 533573 NSE Symbol: APLLTD
Dear Sir/Madam,
Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and
Participants) Regulations, 2018 for the quarter and half year ended 30th
September, 2026
With reference to the captioned matter, please find enclosed herewith a Certificate
under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for
the quarter and half year ended 30th September, 2026 received from M/s. MUFG lntime
India Private Limited (Formerly known as M/s. Link lntime India Private Limited),
Registrar and Share Transfer Agent of our Company.
We request you to kindly take the same on record.
Thanking you,
Yours faithfully,
For Alembic Pharmaceuticals Limited
Chirag K. Shukla
Company Secretary
Encl.: A/a.
ALEMBIC PHARMACEUTICALS LIMITED
REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229
Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123
MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
CIN: U67190MH1999PTC118368
Registered Address:
C-101, Embassy 247, L.B.S. Marg,
Vikhroli (West), Mumbai - 400083.
Tel: +91 22 4918 6000
www.in.mpms.mufg.com
To, Date : 03-10-2026
The Compliance Officer/ Company Secretary
ALEMBIC PHARMACEUTICALS LIMITED
ALEMBIC ROAD,
VADODARA
PINCODE : 390003
Sub : Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and
Participants) Regulations, 2018.
Dear Sir/Madam,
In reference to the above captioned regulation, we hereby confirm that the securities received from the depository
participants for dematerialisation during the quarter ended 30th September 2026, were confirmed (accepted/rejected) to the
depositories by us and that securities comprised in the said certificates have been listed on the stock exchanges where the
earlier issued securities are listed.
We hereby also confirm that the security certificates received for dematerialisation have been confirmed/rejected and the
security certificates received were mutilated and cancelled after due verification by the depository participant and the name
of the depositories have been substituted in the register of members as the registered owner within the prescribed timelines.
We request you to kindly take note of the above in your records.
Thanking you,
Yours faithfully,
For MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
Ashok Shetty
Sr. Vice President-Corporate Registry
MUFG Intime India Private Limited
A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services